These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6218664)

  • 21. Oligonucleotide typing is a perfect tool to identify antigens stimulatory in the mixed lymphocyte culture.
    Termijtelen A; Erlich HA; Braun LA; Verduyn W; Drabbels JJ; Schroeijers WE; van Rood JJ; de Koster HS; Giphart MJ
    Hum Immunol; 1991 Aug; 31(4):241-5. PubMed ID: 1680836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of HLA-D differences.
    Suciu-Foca N; Rubinstein P; Susinno E; Broell J; Weiner J; Reemtsma K
    Tissue Antigens; 1978 Aug; 12(2):94-105. PubMed ID: 81541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: matching for transplants from related haploidentical donors.
    Mickelson EM; Guthrie LA; Etzioni R; Anasetti C; Martin PJ; Hansen JA
    Tissue Antigens; 1994 Aug; 44(2):83-92. PubMed ID: 7817382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-D and -DR antigens on human amniotic fluid cells. I. Lack of expression of HLA-D.
    Valentine-Thon E; Kreeb G; Grosse-Wilde H; Passarge E
    Tissue Antigens; 1983 Feb; 21(2):138-47. PubMed ID: 6221440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of the segregation of MLC reactivity, HLA-D and DR antigens in families].
    Busová B; Buc M; Bártová A; Nyulassy S; Stefanovic J
    Bratisl Lek Listy; 1983; 79(2):198-210. PubMed ID: 6219731
    [No Abstract]   [Full Text] [Related]  

  • 26. HLA-D typing with homozygous cells identified in an American indigenous isolate. II. Family studies and D/DR relationship.
    Layrisse Z; Heinen HD; Simonney N
    Tissue Antigens; 1982 Aug; 20(2):86-99. PubMed ID: 6814010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Typing for human alloantigens with the primed lymphocyte typing technique.
    Morling N; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thomsen M
    Adv Immunol; 1982; 32():65-156. PubMed ID: 6180612
    [No Abstract]   [Full Text] [Related]  

  • 28. HLA-DPB1 allele mismatches between unrelated HLA-A,B,C,DR (generic) DQA1-identical unrelated individuals with unreactive MLC.
    Salazar M; Yunis I; Alosco SM; Chopek M; Yunis EJ
    Tissue Antigens; 1992 Apr; 39(4):203-8. PubMed ID: 1356283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of HLA-D matching on the outcome of intrafamilial kidney transplantation with special emphasis on the predictive value of the relative response in MLC.
    Berg B; Groth CG; Lundgren G; Magnusson G; Möller E; Ringdén O
    Scand J Urol Nephrol Suppl; 1981; 64():46-51. PubMed ID: 6216584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neopterin release in human mixed lymphocyte culture: requirement of HLA-DR disparity.
    Niederwieser D; Albert E; Fuchs D; Hausen A; Margreiter R; Reibnegger G; Schönitzer D; Troppmair J; Wachter H; Huber C
    Immunol Lett; 1985; 11(2):95-9. PubMed ID: 2935492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of HLA-DR antigens with the autologous mixed lymphocyte reaction.
    Davey FR; Kurec AS; Dock NL; Hubbell C; Falen SW
    Tissue Antigens; 1984 Aug; 24(2):98-106. PubMed ID: 6238447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of low donor-specific MLR versus HLA-DR compatibility on kidney graft survival.
    Langhoff E; Jakobsen BK; Platz P; Ryder LP; Svejgaard A
    Transplantation; 1985 Jan; 39(1):18-21. PubMed ID: 2578235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenetic analysis of HLA-DR10 homozygous individuals.
    Young NT; Thompson J; Gibson K; Dewar K; Darke C
    Eur J Immunogenet; 1995 Apr; 22(2):191-7. PubMed ID: 7605777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-DR antigens in Chinese-American families.
    Colombe B; Pask S; Cann H; Payne R
    Hum Immunol; 1982 Jun; 4(3):229-38. PubMed ID: 6811514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MHC in human bone marrow allotransplantation.
    Yunis EJ; Awdeh Z; Raum D; Alper CA
    Clin Haematol; 1983 Oct; 12(3):641-80. PubMed ID: 6227438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants.
    Zeevi A; Scheffel C; Annen K; Bass G; Marrari M; Duquesnoy RJ
    Immunogenetics; 1982; 16(3):209-18. PubMed ID: 6183198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of matching for HLA-DR antigens on skin graft survival.
    Jonker M; Hoogeboom J; van Leeuwen A; Koch CT; Blussé van Oud Alblas D; van Rood JJ
    Transplantation; 1979 Feb; 27(2):91-4. PubMed ID: 380076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of unrelated bone marrow donors: does the current procedure warrant complete MHC class II identity?
    Eiermann TH; Ballas M; Fakler J; Müller C; Wölpl A; Goldmann SF
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):127-9. PubMed ID: 1498553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.